Chapter closes on trial of Georgia distributor of knockoff branded products
Company imported knockoffs from Belize and sold them over the Internet
As reported by MSNBC, Jared Wheat, president of Hi-Tech Pharmaceuticals (Norcross, GA) accepted a plea bargain in federal court for illegally selling the drugs, and will serve a 50-month sentence. The company and other individual defendants will forfeit $3 million in illicit proceeds. However, charges from other alleged actions, including racketeering, and selling diet supplements spiked with ephendrine, were dropped.
Stemming from investigations that concluded with arrests in 2006, Hi-Tech was accused of running a manufacturing facility in Belize from which it imported “generic” versions of Xanax, Valium, Ambien, Zoloft and other branded products. In interviews with MSNBC, West had contended that the products were legal because patent protections for them did not exist in Belize.
How Industry Stakeholders View Medicare Advantage Expansion for Patients with Kidney Disease
July 7th 2025A qualitative study explores how MA plan leaders, kidney care managers, and dialysis providers perceive the benefits, risks, and marketing practices surrounding MA enrollment for patients with end-stage kidney disease.
Multi-Indication Drug Branding in Today’s Pharmaceutical Industry
July 2nd 2025As drug development increasingly targets multiple indications, pharma companies must make strategic branding decisions—balancing regulatory requirements, market dynamics, and patient safety—to choose between single-brand or multi-brand approaches.
